The “Aa2” rating is based on numerous factors, including Mayo’s large size, demonstrated national and international draw for patients and strong fundraising ability.
Offsetting these strengths is Mayo Clinic’s support of research and education activities that suppress adjusted margins.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Mayo will continue to generate adequate adjusted operating margins and sustain liquidity ratios.
More articles on healthcare finance:
RCM startup insider: MedPilot
Proposal to fund Okla. Medicaid program with cigarette tax gets backing from healthcare groups
Ascension to issue $1.34B in bonds to refinance Ministry hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
